NCT06009731

Brief Summary

Currently, measurement of transdiaphragmatic pressure (Pdi) using oesophageal and gastric balloons is the gold standard for the assessment of diaphragmatic effort. This technique is relatively invasive and its interpretation may be complex. The diaphragmatic longitudinal strain (LSdi) and strain rate (LSRdi) might provide additional information in the assessment of diaphragmatic effort and movement during SBT, allowing early detection of diaphragmatic dysfunction. Patients will be monitored during a 30-120 minutes SBT consisting of no assistance on the ventilator using CPAP with a pressure level of 0 cmH2O. Parameters to evaluate diaphragm function will include diaphragmatic strain (LSdi and LSRdi), diaphragmatic thickening fraction (TFdi), and airway occlusion pressure (ΔP0.1 and ΔPocc). These parameters will be measured immediately before ('baseline') the SBT, as well as 2 minutes ('early' assessment), 15 ('intermediate' assessment) and 30 minutes ('late' assessment) after the beginning of the SBT.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 12, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 18, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 24, 2023

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

August 24, 2023

Status Verified

July 1, 2023

Enrollment Period

2 years

First QC Date

July 18, 2023

Last Update Submit

August 22, 2023

Conditions

Keywords

weaningspontaneous breathing trialmechanical ventilationspeckle trackingStrainsdiaphragm

Outcome Measures

Primary Outcomes (2)

  • changes of diaphragmatic longitudinal strain between baseline and during Spontaneous breathing trial

    diaphragmatic longitudinal strain is LSdi Spontaneous breathing trial is SBT

    7 days

  • changes of diaphragmatic longitudinal strain strain rate between baseline and during Spontaneous breathing trial

    diaphragmatic longitudinal strain strain rate is LSRdi Spontaneous breathing trial is SBT

    7 days

Study Arms (1)

adult patients undergoing mechanical ventilation

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Consecutive adult patients (≥18 years old) undergoing mechanical ventilation for at least 24h (regardless of the reason of intubation) and fulfilling criteria for an SBT will be included in the study. Briefly, to be eligible for an SBT, patients will have to (i) be able to trigger ventilator breaths with a reasonable level of assistance, (ii) lack of severe impairment in gas exchange, and (iii) not require significant hemodynamic support. Patients will be recruited by the study coordinator following completion of informed consent from the patient or legally authorized substitute decision maker.

You may qualify if:

  • Consecutive adult patients (≥18 years old) undergoing mechanical ventilation for at least 24h (regardless of the reason of intubation)
  • patients fulfilling criteria for an SBT
  • patients will have to be able to trigger ventilator breaths with a reasonable level of assistance,
  • patients with lack of severe impairment in gas exchange,
  • patients that not require significant hemodynamic support.
  • Patients will be recruited by the study coordinator following completion of informed consent from the patient or legally authorized substitute decision maker.

You may not qualify if:

  • Use of pressure support during the SBT.
  • Severe hemodynamic instability (\>30% increase in vasopressors in the last 6 hours or norepinephrine \> 0.5 µg/kg/min).
  • Severe or very severe chronic obstructive pulmonary disease (COPD) according to the GOLD criteria (stage III: FEV1 30-50% predicted; stage IV: FEV1 \< 30% predicted).
  • Known or suspected severe or progressive neuromuscular disorder likely to result in prolonged or chronic ventilator dependence
  • Clinical judgement of the attending physician.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Amiens

Amiens, 80480, France

RECRUITING

MeSH Terms

Conditions

Sprains and Strains

Condition Hierarchy (Ancestors)

Wounds and Injuries

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 18, 2023

First Posted

August 24, 2023

Study Start

June 12, 2023

Primary Completion

June 1, 2025

Study Completion

June 1, 2025

Last Updated

August 24, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations